189 related articles for article (PubMed ID: 18050376)
21. Abatacept: a novel treatment for moderate-to-severe rheumatoid arthritis.
Reynolds J; Shojania K; Marra CA
Pharmacotherapy; 2007 Dec; 27(12):1693-701. PubMed ID: 18041889
[TBL] [Abstract][Full Text] [Related]
22. Improving patient outlook in rheumatoid arthritis: experience with abatacept.
Coughlin M
J Am Acad Nurse Pract; 2008 Oct; 20(10):486-95. PubMed ID: 19128344
[TBL] [Abstract][Full Text] [Related]
23. Abatacept for systemic lupus erythematosus: the outlook.
Mok CC
Expert Opin Biol Ther; 2012 Dec; 12(12):1559-61. PubMed ID: 22946545
[TBL] [Abstract][Full Text] [Related]
24. T-cell agents in the treatment of rheumatoid arthritis.
Solomon GE
Bull NYU Hosp Jt Dis; 2010; 68(3):162-5. PubMed ID: 20969545
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study.
Burge DJ; Bookbinder SA; Kivitz AJ; Fleischmann RM; Shu C; Bannink J
Clin Ther; 2008 Oct; 30(10):1806-16. PubMed ID: 19014836
[TBL] [Abstract][Full Text] [Related]
26. Drug Insight: abatacept for the treatment of rheumatoid arthritis.
Ruderman EM; Pope RM
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):654-60. PubMed ID: 17133250
[TBL] [Abstract][Full Text] [Related]
27. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation.
Vincenti F; Luggen M
Annu Rev Med; 2007; 58():347-58. PubMed ID: 17020493
[TBL] [Abstract][Full Text] [Related]
28. [Effect of CTLA4-Ig on radiographic outcome of patients with rheumatoid arthritis].
Harigai M
Clin Calcium; 2007 Apr; 17(4):577-84. PubMed ID: 17404488
[TBL] [Abstract][Full Text] [Related]
29. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.
Knoerzer DB; Karr RW; Schwartz BD; Mengle-Gaw LJ
J Clin Invest; 1995 Aug; 96(2):987-93. PubMed ID: 7543497
[TBL] [Abstract][Full Text] [Related]
30. [CTLA4-Ig (abatacept)].
Harigai M
Nihon Rinsho; 2007 Jul; 65(7):1231-7. PubMed ID: 17642237
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacological properties and clinical efficacy of abatacept (Orencia(®)) for the treatment of rheumatoid arthritis].
Yasuoka Y; Goto A; Seriu T
Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):87-94. PubMed ID: 21321458
[No Abstract] [Full Text] [Related]
32. Modeling and simulation of abatacept exposure and interleukin-6 response in support of recommended doses for rheumatoid arthritis.
Roy A; Mould DR; Wang XF; Tay L; Raymond R; Pfister M
J Clin Pharmacol; 2007 Nov; 47(11):1408-20. PubMed ID: 17962428
[TBL] [Abstract][Full Text] [Related]
33. Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.
Emery P; Kosinski M; Li T; Martin M; Williams GR; Becker JC; Blaisdell B; Ware JE; Birbara C; Russell AS
J Rheumatol; 2006 Apr; 33(4):681-9. PubMed ID: 16568505
[TBL] [Abstract][Full Text] [Related]
34. Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom.
Guyot P; Taylor PC; Christensen R; Pericleous L; Drost P; Eijgelshoven I; Bergman G; Lebmeier M
J Rheumatol; 2012 Jun; 39(6):1198-206. PubMed ID: 22505698
[TBL] [Abstract][Full Text] [Related]
35. Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis.
Scarsi M; Ziglioli T; Airo' P
J Rheumatol; 2011 Oct; 38(10):2105-11. PubMed ID: 21807779
[TBL] [Abstract][Full Text] [Related]
36. Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis.
Korhonen R; Moilanen E
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):276-84. PubMed ID: 19228144
[TBL] [Abstract][Full Text] [Related]
37. Investigation into the impact of abatacept on sleep quality in patients with rheumatoid arthritis, and the validity of the MOS-Sleep questionnaire Sleep Disturbance Scale.
Wells G; Li T; Tugwell P
Ann Rheum Dis; 2010 Oct; 69(10):1768-73. PubMed ID: 20610444
[TBL] [Abstract][Full Text] [Related]
38. Update on abatacept: a selective costimulation modulator for rheumatoid arthritis.
Bruce SP; Boyce EG
Ann Pharmacother; 2007 Jul; 41(7):1153-62. PubMed ID: 17609234
[TBL] [Abstract][Full Text] [Related]
39. A nursing guide to infusion therapy with abatacept for the treatment of rheumatoid arthritis.
Barr C
J Infus Nurs; 2007; 30(2):96-104; quiz 120. PubMed ID: 17413494
[TBL] [Abstract][Full Text] [Related]
40. Abatacept mechanism of action: concordance with its clinical profile.
Herrero-Beaumont G; Martínez Calatrava MJ; Castañeda S
Reumatol Clin; 2012; 8(2):78-83. PubMed ID: 22104048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
